Browse Category

Solutions - Page 4

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Amid Wegovy pill’s flying start in US, Novo CEO eyes Ireland expansion for supply overseas: Bloomberg

Novo plans to invest in an expansion of its facility in Athlone, Ireland, to produce its Wegovy pill for markets beyond the U.S., the company’s CEO, Mike Doustdar, told Bloomberg News in

February 12, 2026

News·Solutions

Taiwan’s PharmaEssentia to build $46M manufacturing plant in Puerto Rico

PharmaEssentia will spend $46 million to build a manufacturing facility in Puerto Rico. The move forms part of the Taiwanese biotech’s global expansion strategy to support demand for its rare blood disease

February 10, 2026

News·Solutions

Moderna inks long-term pact with Mexico to bolster local mRNA vaccine supply

The agreement includes mRNA vaccine supply and a technology transfer that allows Mexico’s Laboratorios Liomont to produce Moderna’s 2025-2026 COVID vaccine.

February 10, 2026

News·Solutions

Fresenius Kabi, Phlow ink US onshoring alliance to boost epinephrine injection supply

The agreement will see Phlow as the first drugmaker to produce epinephrine injection API in the U.S., while Fresenius will work on formulation and finished doses to ship to U.S. hospitals and

February 9, 2026

News·Solutions

OXB expands BMS partnership to churn out lentiviral vectors for commercial CAR-Ts

OXB, a U.K.-based cell and gene therapy manufacturer, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs.

February 4, 2026

News·Solutions

AI in Medical Devices: Safety Questions the Industry Can’t Afford to Ignore

Performance Is Not the Same as Safety For years, AI evaluation has centered on accuracy, sensitivity, specificity, and other statistical measures. These metrics are useful, but they describe performance under controlled conditions.

February 3, 2026

Solutions

India will invest $1.1B to boost development of biologics, biosimilars

Long known for manufacturing generics, vaccines and small-molecule drugs, India is attempting to shift its focus, with a big boost from its government. The country will invest 100 billion rupees ($1.1 billion)

February 3, 2026

News·Solutions

Sweden’s Nanologica acquires API facility from CDMO Ardena, brings team of 45 on board

Nanologica, a life sciences company that makes silica-based peptides for the pharmaceutical industry, acquired CDMO Ardena’s Syntagon manufacturing facility in a stock deal valued at 8.6 million Swedish kroner ($961,000).

February 3, 2026

News·Solutions

Thermo Fisher trims Massachusetts headcount with Franklin site closure

Thermo Fisher is continuing its recent layoff spree with a fresh round of cuts tied to a site it’s shuttering in Franklin, Massachusetts, which currently employs about 200 people.

February 2, 2026

News·Solutions

CDMO Vetter maps out expansion in Germany with €480M for new plant

The German CDMO devoted 480 million euros ($574.3 million) to the first construction phase for a new plant in Saarlouis, Germany, which is expected to be operational by 2031.

January 29, 2026

News·Solutions

Previous 1 2 3 4 5 6 … 14 Next

Go toTop